Back
Getinge AB Vs. Hansa Biopharma AB Industry Stock Comparison
Sell
38
GNGBF
Getinge AB
Last Price:
17.00
Seasonality Move:
1.65%
Sell
39
HNSBF
Hansa Biopharma AB
Last Price:
2.83
Seasonality Move:
-3.19%
Sell
38
Getinge AB (GNGBF)
is a Sell
Is Getinge AB a Buy, Sell or Hold?
- The current Getinge AB [GNGBF] share price is $17.00. The Score for GNGBF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- GNGBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy, Sell or Hold?
- The current Hansa Biopharma AB [HNSBF] share price is $2.83. The Score for HNSBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HNSBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GNGBF Stock Price Chart
What is Getinge AB's stock price today?
-
The Getinge AB share price today is $17.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNGBF is experiencing slight buying pressure.
HNSBF Stock Price Chart
What is Hansa Biopharma AB's stock price today?
-
The Hansa Biopharma AB share price today is $2.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNSBF is experiencing slight buying pressure.
GNGBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.47 | Sell |
Relative Strength Index (14 RSI): | 2.54 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.82 - 17.44) | Sell |
Bollinger Bands (100): | (18.09 - 21.25) | Sell |
HNSBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 8.68 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.01 - 3.77) | Sell |
Bollinger Bands (100): | (2.8 - 3.48) | Sell |
GNGBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17 | Sell |
20-day SMA: | 17 | Sell |
50-day SMA: | 18.86 | Sell |
200-day SMA: | 20.02 | Sell |
8-day EMA: | 17 | Sell |
20-day EMA: | 17.29 | Sell |
50-day EMA: | 18.34 | Sell |
200-day EMA: | 19.75 | Sell |
HNSBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.83 | Sell |
20-day SMA: | 3.32 | Sell |
50-day SMA: | 3.35 | Sell |
200-day SMA: | 3.05 | Sell |
8-day EMA: | 2.94 | Sell |
20-day EMA: | 3.18 | Sell |
50-day EMA: | 3.27 | Sell |
200-day EMA: | 3.64 | Sell |
Getinge AB Earnings Growth & GNGBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hansa Biopharma AB Earnings Growth & HNSBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Getinge AB Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Hansa Biopharma AB Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |